Back
Clene 10K Form
Sell
23
CLNN
Clene
Last Price:
4.80
Seasonality Move:
-22.53%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
| 2021-03-29 | 10K | CLNN/Clene Annual |
| 2020-11-03 | 10Q | CLNN/Clene Quarterly |
| 2020-09-04 | 10K | CLNN/Clene Annual |
| 2020-08-03 | 10Q | CLNN/Clene Quarterly |
| 2020-05-14 | 10Q | CLNN/Clene Quarterly |
| 2020-03-24 | 10K | CLNN/Clene Annual |
Receive CLNN News And Ratings
See the #1 stock for the next 7 days that we like better than CLNN
CLNN Financial Statistics
Sales & Book Value
| Annual Sales: | $654K |
|---|---|
| Cash Flow: | $-6.36M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $-0.08 |
| Price / Book: | 0 |
Profitability
| EPS (TTM): | -4.46000 |
|---|---|
| Net Income (TTM): | $-30.46M |
| Gross Margin: | $533K |
| Return on Equity: | -253.42% |
| Return on Assets: | -57.24% |
Clene Earnings Forecast
Key Clene Financial Ratios
- The Gross Profit Margin over the past 5 years for CLNN is 81.50%.
- The Selling, General & Administrative Expenses for CLNN have been equal to 2,054.13% of Gross Profit Margin.
- The Research & Development expenses have been 4,075.69% of Revenue.
- The Interest Expense is -9.21% of Operating Income.
- The Net Earning history of CLNN is -7,569.42% of Total Revenues.
- Per Share Earnings over the last 6 years have been positive in 1 years.
Clene Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | CLNN |
| CUSIP: | 185634 |
| Website: | clene.com |
Debt
| Debt-to-Equity Ratio: | -54.5 |
|---|---|
| Current Ratio: | 0.99 |
| Quick Ratio: | 0.82 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |